Dr Rachel Archer BSc, PhD (Sheffield) (formerly Jackson)

Archer1

Research Fellow

HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 1019

Tel: (+44) (0)114 222 0793
Fax: (+44) (0)114 222 0749

Email: r.archer@sheffield.ac.uk

ORCiD: 0000-0003-0704-4762

Biography

I read for my first degree in genetics and microbiology before undertaking a PhD and postdoctoral research in molecular microbiology. I joined the Section of Public Health at ScHARR in August 2004 before moving to HEDS in August 2007.

Research interests

My research interests include:
• systematic reviews of clinical effectiveness evidence
• systematic reviews of public health interventions
• development of methods for systematic reviewing and evidence synthesis

Teaching interests

I am currently involved as a lecturer in the teaching of systematic review methods on undergraduate and postgraduate taught courses. I lead the delivery of a successful external short course in systematic review methods entitled The ScHARR systematic reviews course: Practical skills for undertaking reviews. I also play a strategic role in the delivery of teaching as a member of the HEDS Teaching Functional Working Group.

Professional Activities

I am a member of the ScHARR Technology Assessment Group (ScHARR-TAG) and the ScHARR Public Health Collaborating Centre. I have undertaken leading and contributory roles in high quality research for the National Institute for Health and Clinical Excellence, the NHS and other funding organisations

Recent Projects

I have previously worked on the following projects:
• NICE Single Technology Appraisal of the use of pegloticase in gout
• Assessment of the use of routine echocardiography in the management of stroke and transient ischaemic attack
• NICE Single Technology Appraisal of the use of golimumab in rheumatoid arthritis
• Assessment of evidence to inform Public Health Programme Guidance relating to the prevention and early identification of alcohol use disorders in adults and adolescents (funded by the National Institute for Health and Clinical Excellence) (lead systematic reviewer)
• Health Technology Assessment of the use of oseltamivir, amantadine and zanamivir for the prophylaxis of influenza (commissioned by the National Coordinating Centre for Health Technology Assessment (NCCHTA) on behalf of the National Institute for Health and Clinical Excellence) (lead systematic reviewer)

Extended List of Publications

Journal articles